Molecular docking of 11β-HSD1 with (1,2,4-triazole derivatives) inhibitors in a solvated medium

Co-Authors

Mostefaoui Larbi, Meriem Merad, benmiloud kamal and Said Ghalem*

Citation

merad, Molecular docking of 11?-HSD1 with (1,2,4-triazole derivatives) inhibitors in a solvated medium(-0001)SDRP Journal of Computational Chemistry & Molecular Modelling 2(2)

Abstract

Background: The scope of molecular modeling techniques is enormous, reflecting the spectrum of knowledge and scientific domains that may be involved. It can be valuable in the identification of therapeutic targets, typically protein receptors whose specific role in a pathology is characterized. It may then prove indispensable in the development of chemical inhibitors for this target.1, 2, 4 triazol derivatives are recommended in treatment of hypertension.

Methods:The study of the interaction of the enzyme 11β-HSD1 - derived from 1, 2, 4-triazol by molecular modeling and precisely the molecular docking in solvated and unsolvated medium leads to the most stable complex. This study is based on the comparison of the theoretical and experimental results of the literature.

Results: Molecules 1,2,4 triazol derivatives  interact differently with blood pressure enzyme (11β-HSD1) and confirm primary studies concerning1,2,4-triazol derivativesare good inhibitors for high blood pressure.

Conclusion: 11β-HSD1) enzyme with by molecular modeling by using  molecular docking to confirm the experimental studies of 11β-HSD1 inhibitors reduce Medium

Keywords: Enzyme 11β-HSD1, molecular docking, solvation

References

  1. NouhoumOuologuem? place de l'hypertension arterielle dans la pathologie cardiovasculaire dans le district de bamako en 2002 ? th?se de doctorat ; la Facult? de M?decine, de Pharmacie et d'Odontostomatologie ;universite de bamako, Mali2005.

  2. R. Lavery. ? La mod?lisation mol?culaire : un outil pour ?tudier les macromol?cules biologiques et leurs interactions. De la mati?re au vivant : les syst?mes mol?culaires organis?s ?. P a r i s : CNRS- Images de la Recherche, p. 199?204, (1994).

  3. Nathalie BASDEVANT ? Un Mod?le de Solvatation Semi-Implicite pour la Simulation des Macromol?cules Biologiques ? ; th?se de doctorat universite d'evryval-d'essonne, p56, 2003

  4. Molecular operating environment (MOE) chemical computing group,montrealquebec , canada 10 ,2012

  5. Robb, G.R., Boyd, S., Davies, C.D., Dossiter, A.G., Goldberg, F.W., Kemmitt, P.D., Scott, J.S., Swales, J.G." Design of pyrozolo-pyrimidines as 11beta-HSD1 inhibitors through optimisation of molecular electrostatic potential". Med chem. Comm 6: 926-934; 2016

    View Article           

  6. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings". Adv. Drug Deliv. Rev. 46 (1-3): 3?26. (March 2001) 00129-0

    View Article           

  7. Lipinski CA "Lead- and drug-like compounds: the rule-of-five revolution". Drug DiscoveryToday: Technologies 1 (4): 337?341. (December 2004). PMid:24981612

    View Article      PubMed/NCBI     

  8. hyperchem (molecularmodeling system)hypercube ,inc.,1115NW 4th street, gainesville,FL32601,USA,2005.

  9. Mar?chal, Yvus. "The hydrogen bond and the water molecule"Elsevier Science & Technology": eBook ISBN: 9780080469294. Hardcover ISBN:9780444519573, 2007.

  10. HichamAyachi, ShirinJamshidi, MeriemMerad, YassineBendiabdallah, Said Ghalem,KhondakerMiraz Rahman "Design of New Inhibitors ofDipeptidyl Peptidase-4 in Type 2 Diabetes byComputer Simulations ?Der PharmaChemica, 9(2):17-29,2017

  11. David R. Bauman a, Alan Whitehead b, Lisa C. Contino c, Jisong Cui a, Margarita Garcia-Calvo d, XinGub,Nancy Kevin b, Xiuying Mac, Lee-yuhPai c, Kashmira Shah c, XiaolanShen e, Sloan Stribling c, Hratch J. Zokian d, Joe Metzger c, Diane E. Shevell a, Sherman T. Waddell b,"Evaluation of selective inhibitors of 11b-HSD1 for the treatment of hypertension";Bioorganic & Medicinal Chemistry Letters 23 3650?3653,2013.

  12. WL Jorgensen,"themanyrolesof computation in drug discovery", science-sciencemag.org.303:1813-1818, 2004.

  13. A.Imberty, K. D. Hardman, J.P. Carver, S. P?rez:" Molecular of protein-carbohydrate interactions. Docking of monosaccharide's in the binding site ofconcanavaline a",glycobiology, 1, 631?642, 1991.

We publish articles under Creative Common License (CC-BY) that ensure that all published papers are immediately and permanently available online for everyone, worldwide.
Submit Manuscript